EUVIMEDEUVIMED entdecken
Crossref

Neuromarketing under ethical scrutiny: Regulatory gaps, risks of cognitive manipulation, and governance challenges in neuro-assisted decision-making contexts

Edison Rolando Sánchez Pallo

Multidisciplinary Reviews · 13.10.2026 · 10 (4) · 2027233

DOI: 10.31893/multirev.2027233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multidisciplinary Reviews, online erschienen am 13.10.2026. Verfasst von Edison Rolando Sánchez Pallo. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study critically examines neuromarketing from ethical, regulatory, and corporate governance perspectives considering the significant increase in the use of neuroscientific techniques in corporate decision-making. The research is grounded in the recognition of a growing informational asymmetry between companies and consumers resulting from access to neurophysiological data capable of influencing cognitive processes, thereby raising concerns related to manipulation, mental privacy, and decision-making autonomy. A narrative critical review of the scientific literature published between 2018 and 2025 was conducted using the following databases: Scopus, Web of Science, PubMed, IEEE Xplore, and ScienceDirect. From the selected documentation, 38 articles were analyzed according to the categories of consumer autonomy, informed consent, potential cognitive manipulation, neuroprivacy vulnerabilities, and ethical governance. The results indicate a significant increase in research since 2020 and a predominance of techniques such as EEG, eye-tracking, fMRI, and GSR. The main ethical risks identified include the erosion of consumer autonomy, limitations of informed consent, potential cognitive manipulation, neuroprivacy vulnerabilities, and the commercial use of neurophysiological data. A clear distinction also emerged between the more critical academic approach and the more instrumental corporate perspective. The findings demonstrate that the ethical risks of neuromarketing are structural and are exacerbated by the absence of specific regulatory frameworks for neuronal data. The reliance on general data protection regulations is insufficient, transferring ethical responsibility to companies and increasing reputational and regulatory risks. The study highlights the urgent need for specific regulatory frameworks, ethical governance strategies, and corporate self-regulation mechanisms. Neuromarketing must be integrated into corporate social responsibility models and public policies that promote autonomy and neuroprivacy, positioning it as a key issue at the intersection of contemporary business ethics.

Zitieren

APA

Pallo, E. R. S. (2026). Neuromarketing under ethical scrutiny: Regulatory gaps, risks of cognitive manipulation, and governance challenges in neuro-assisted decision-making contexts. Multidisciplinary Reviews, 10(4), 2027233. https://doi.org/10.31893/multirev.2027233

Vancouver

Pallo ERS. Neuromarketing under ethical scrutiny: Regulatory gaps, risks of cognitive manipulation, and governance challenges in neuro-assisted decision-making contexts. Multidisciplinary Reviews. 2026;10(4):2027233. doi:10.31893/multirev.2027233

BibTeX
@article{Pallo2026,
  author = {Pallo, Edison Rolando Sánchez},
  title = {Neuromarketing under ethical scrutiny: Regulatory gaps, risks of cognitive manipulation, and governance challenges in neuro-assisted decision-making contexts},
  journal = {Multidisciplinary Reviews},
  year = {2026},
  volume = {10},
  number = {4},
  pages = {2027233},
  doi = {10.31893/multirev.2027233}
}
Kostenlos starten →